Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track QUIT with free AI briefings, catalyst countdowns, and dilution alerts.

QUIT · ACHIEVE LIFE SCIENCES, INC.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$201.5M Cash on Hand
54.9mo Cash Runway
Follow QUIT by email Get an email when QUIT reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about QUIT, unsubscribe in one click. Privacy

📣 What QUIT Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

QUIT holds $201.5M in cash and short-term investments and burns about $11M/quarter from operations, an estimated runway of 54.9 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 45 · Elevated

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when QUIT files for a raise →

👥 Who Owns QUIT

Insiders 7.1% Other 5%+ holders 34.6% Institutions (162 holders) 58.3% Public and other holders 0%
HolderTypeShares% of sharesAs of
venBio Global Strategic Fund V, L.P. 5%+ holder (13D) 10,737,317 9.76% 2026-04-15
Logos Global Management LP Institution (13G, 5%+) 10,538,440 9.58% 2026-05-11
Paradigm BioCapital Advisors LP 5%+ holder (13G) 9,903,712 9.00% 2026-04-17
Franklin Resources, Inc. Institution (13G, 5%+) 8,878,942 8.07% 2026-06-30
TPG GP A, LLC
10% owner
Insider 6,877,580 6.25% 2026-04-17
Frazier Life Sciences Public Fund, L.P. 5%+ holder (13G) 6,625,788 6.02% 2026-04-17
JANUS HENDERSON GROUP Ltd. Institution (13G, 5%+) 5,502,064 5.00% 2026-06-30
Venrock Healthcare Capital Partners III, 5%+ holder (13G) 5,502,064 5.00% 2026-04-17
Vivo Opportunity, LLC 5%+ holder (13G) 5,305,640 4.82% 2026-07-06
BlackRock, Inc. Institution (13G, 5%+) 5,271,391 4.79% 2026-06-30
Thomas Braxton King
Director
Insider 315,142 0.29% 2025-09-04
Richard Alistair Stewart
Director · +686,700 options
Insider 209,490 0.19% 2026-08-19

Share count 110,034,457 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full QUIT picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for QUIT and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.